NVRO Nov 2024 12.500 call
| Previous Close | 1.9000 |
| Open | 1.9000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 12.50 |
| Expire Date | 2024-11-15 |
| Day's Range | 1.9000 - 1.9000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 2 |
PR NewswireNevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on May 7, 2024, the Compensation Committee of the Company's Board of Directors granted inducement restricted stock unit awards covering 59,460 shares of Nevro's common stock to twenty-six new non-executive employees to induce them to accept employment with Nevro. Each award was granted under the Nevro Corp. 2023 Inducement Award Pla
Simply Wall St.Earnings Release: Here's Why Analysts Cut Their Nevro Corp. (NYSE:NVRO) Price Target To US$15.30
Nevro Corp. ( NYSE:NVRO ) investors will be delighted, with the company turning in some strong numbers with its latest...
- PR Newswire
Nevro to Present at BofA Securities 2024 Healthcare Conference
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that members of its management team will participate in the BofA Securities 2024 Healthcare Conference on Tuesday, May 14, 2024. The company's formal presentation will begin at 9:20 am PDT (12:20 am EDT).
